
    
      To prospectively collect and assess safety and efficacy data on the AcoArt drug-coated PTA
      balloon catheters carrying the CE Mark per current Instructions for Use in a real-world
      cohort of patients with symptomatic arterial disease undergoing endovascular lower limb
      revascularization per the institution's standard practice.
    
  